Trial Outcomes & Findings for A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash (NCT NCT00891982)

NCT ID: NCT00891982

Last Updated: 2017-05-24

Results Overview

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

60 participants

Primary outcome timeframe

Screening/baseline

Results posted on

2017-05-24

Participant Flow

Participant milestones

Participant milestones
Measure
CTGel Plus BPO Wash
BPO Wash in the morning and CTGel in the evening
CTGel
Soap Free Cleanser in the morning and CTGel in the evening
Overall Study
STARTED
30
31
Overall Study
COMPLETED
28
30
Overall Study
NOT COMPLETED
2
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Total
n=61 Participants
Total of all reporting groups
Age, Customized
<18 years
16 participants
n=99 Participants
14 participants
n=107 Participants
30 participants
n=206 Participants
Age, Customized
Between 18 and 45 years
14 participants
n=99 Participants
17 participants
n=107 Participants
31 participants
n=206 Participants
Sex: Female, Male
Female
18 Participants
n=99 Participants
20 Participants
n=107 Participants
38 Participants
n=206 Participants
Sex: Female, Male
Male
12 Participants
n=99 Participants
11 Participants
n=107 Participants
23 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants
n=99 Participants
5 Participants
n=107 Participants
11 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
24 Participants
n=99 Participants
26 Participants
n=107 Participants
50 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race/Ethnicity, Customized
Black or African American
2 Participants
n=99 Participants
3 Participants
n=107 Participants
5 Participants
n=206 Participants
Race/Ethnicity, Customized
White
24 Participants
n=99 Participants
28 Participants
n=107 Participants
52 Participants
n=206 Participants
Race/Ethnicity, Customized
More than one race
4 Participants
n=99 Participants
0 Participants
n=107 Participants
4 Participants
n=206 Participants
Region of Enrollment
United States
30 participants
n=99 Participants
31 participants
n=107 Participants
61 participants
n=206 Participants
ISGA
Grade 2
9 participants
n=99 Participants
11 participants
n=107 Participants
20 participants
n=206 Participants
ISGA
Grade 3
18 participants
n=99 Participants
15 participants
n=107 Participants
33 participants
n=206 Participants
ISGA
Grade 4
3 participants
n=99 Participants
5 participants
n=107 Participants
8 participants
n=206 Participants

PRIMARY outcome

Timeframe: Screening/baseline

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Local Tolerability - Skin Dryness
Grade 0
28 participants
26 participants
Local Tolerability - Skin Dryness
Grade 1
2 participants
4 participants
Local Tolerability - Skin Dryness
Grade 2
0 participants
1 participants
Local Tolerability - Skin Dryness
Grade 3
0 participants
0 participants
Local Tolerability - Skin Dryness
Grade 4
0 participants
0 participants
Local Tolerability - Skin Dryness
Grade 5
0 participants
0 participants
Local Tolerability - Skin Dryness
Missing
0 participants
0 participants

PRIMARY outcome

Timeframe: Week 1

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Local Tolerability - Skin Dryness
Missing
1 participants
1 participants
Local Tolerability - Skin Dryness
Grade 0
12 participants
16 participants
Local Tolerability - Skin Dryness
Grade 1
5 participants
8 participants
Local Tolerability - Skin Dryness
Grade 2
5 participants
5 participants
Local Tolerability - Skin Dryness
Grade 3
6 participants
0 participants
Local Tolerability - Skin Dryness
Grade 4
0 participants
1 participants
Local Tolerability - Skin Dryness
Grade 5
1 participants
0 participants

PRIMARY outcome

Timeframe: Week 2

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Local Tolerability - Skin Dryness
Grade 0
15 participants
17 participants
Local Tolerability - Skin Dryness
Grade 1
7 participants
8 participants
Local Tolerability - Skin Dryness
Grade 2
5 participants
4 participants
Local Tolerability - Skin Dryness
Grade 3
1 participants
0 participants
Local Tolerability - Skin Dryness
Grade 4
0 participants
0 participants
Local Tolerability - Skin Dryness
Grade 5
0 participants
0 participants
Local Tolerability - Skin Dryness
Missing
2 participants
2 participants

PRIMARY outcome

Timeframe: Week 4

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Local Tolerability - Skin Dryness
Grade 0
19 participants
19 participants
Local Tolerability - Skin Dryness
Grade 1
7 participants
11 participants
Local Tolerability - Skin Dryness
Grade 2
2 participants
1 participants
Local Tolerability - Skin Dryness
Grade 3
0 participants
0 participants
Local Tolerability - Skin Dryness
Grade 4
0 participants
0 participants
Local Tolerability - Skin Dryness
Grade 5
0 participants
0 participants
Local Tolerability - Skin Dryness
Missing
2 participants
0 participants

PRIMARY outcome

Timeframe: Screening/baseline

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Local Tolerability - Skin Scaling
Grade 0
29 Participants
28 Participants
Local Tolerability - Skin Scaling
Grade 1
1 Participants
2 Participants
Local Tolerability - Skin Scaling
Grade 2
0 Participants
1 Participants
Local Tolerability - Skin Scaling
Grade 3
0 Participants
0 Participants
Local Tolerability - Skin Scaling
Grade 4
0 Participants
0 Participants
Local Tolerability - Skin Scaling
Grade 5
0 Participants
0 Participants
Local Tolerability - Skin Scaling
Missing
0 Participants
0 Participants

PRIMARY outcome

Timeframe: Week 1

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Local Tolerability - Skin Scaling
Grade 0
13 Participants
19 Participants
Local Tolerability - Skin Scaling
Grade 1
5 Participants
5 Participants
Local Tolerability - Skin Scaling
Grade 2
5 Participants
3 Participants
Local Tolerability - Skin Scaling
Grade 3
5 Participants
2 Participants
Local Tolerability - Skin Scaling
Grade 4
1 Participants
1 Participants
Local Tolerability - Skin Scaling
Grade 5
0 Participants
0 Participants
Local Tolerability - Skin Scaling
Missing
1 Participants
1 Participants

PRIMARY outcome

Timeframe: Week 2

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Local Tolerability - Skin Scaling
Grade 0
17 Participants
19 Participants
Local Tolerability - Skin Scaling
Grade 1
6 Participants
6 Participants
Local Tolerability - Skin Scaling
Grade 2
4 Participants
4 Participants
Local Tolerability - Skin Scaling
Grade 3
1 Participants
0 Participants
Local Tolerability - Skin Scaling
Grade 4
0 Participants
0 Participants
Local Tolerability - Skin Scaling
Grade 5
0 Participants
0 Participants
Local Tolerability - Skin Scaling
Missing
2 Participants
2 Participants

PRIMARY outcome

Timeframe: Week 4

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Local Tolerability - Skin Scaling
Grade 0
20 Participants
25 Participants
Local Tolerability - Skin Scaling
Grade 1
6 Participants
5 Participants
Local Tolerability - Skin Scaling
Grade 2
2 Participants
1 Participants
Local Tolerability - Skin Scaling
Grade 3
0 Participants
0 Participants
Local Tolerability - Skin Scaling
Grade 4
0 Participants
0 Participants
Local Tolerability - Skin Scaling
Grade 5
0 Participants
0 Participants
Local Tolerability - Skin Scaling
Missing
2 Participants
0 Participants

PRIMARY outcome

Timeframe: Screening/baseline

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Local Tolerability - Erythema (Redness)
Grade 0
22 Participants
22 Participants
Local Tolerability - Erythema (Redness)
Grade 1
4 Participants
4 Participants
Local Tolerability - Erythema (Redness)
Grade 2
1 Participants
4 Participants
Local Tolerability - Erythema (Redness)
Grade 3
3 Participants
1 Participants
Local Tolerability - Erythema (Redness)
Grade 4
0 Participants
0 Participants
Local Tolerability - Erythema (Redness)
Grade 5
0 Participants
0 Participants
Local Tolerability - Erythema (Redness)
Missing
0 Participants
0 Participants

PRIMARY outcome

Timeframe: Week 1

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Local Tolerability - Erythema (Redness)
Grade 0
10 Participants
18 Participants
Local Tolerability - Erythema (Redness)
Grade 1
8 Participants
5 Participants
Local Tolerability - Erythema (Redness)
Grade 2
8 Participants
2 Participants
Local Tolerability - Erythema (Redness)
Grade 3
3 Participants
3 Participants
Local Tolerability - Erythema (Redness)
Grade 4
0 Participants
2 Participants
Local Tolerability - Erythema (Redness)
Grade 5
0 Participants
0 Participants
Local Tolerability - Erythema (Redness)
Missing
1 Participants
1 Participants

PRIMARY outcome

Timeframe: Week 2

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Local Tolerability - Erythema (Redness)
Grade 0
17 Participants
12 Participants
Local Tolerability - Erythema (Redness)
Grade 1
5 Participants
9 Participants
Local Tolerability - Erythema (Redness)
Grade 2
5 Participants
6 Participants
Local Tolerability - Erythema (Redness)
Grade 3
1 Participants
2 Participants
Local Tolerability - Erythema (Redness)
Grade 4
0 Participants
0 Participants
Local Tolerability - Erythema (Redness)
Grade 5
0 Participants
0 Participants
Local Tolerability - Erythema (Redness)
Missing
2 Participants
2 Participants

PRIMARY outcome

Timeframe: Week 4

Local tolerability and irritation potential based on investigator assessments of dryness, scaling, and erythema in the areas of study product application. Grading will use the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Local Tolerability - Erythema (Redness)
Grade 0
15 Participants
16 Participants
Local Tolerability - Erythema (Redness)
Grade 1
5 Participants
9 Participants
Local Tolerability - Erythema (Redness)
Grade 2
4 Participants
4 Participants
Local Tolerability - Erythema (Redness)
Grade 3
4 Participants
2 Participants
Local Tolerability - Erythema (Redness)
Grade 4
0 Participants
0 Participants
Local Tolerability - Erythema (Redness)
Grade 5
0 Participants
0 Participants
Local Tolerability - Erythema (Redness)
Missing
2 Participants
0 Participants

SECONDARY outcome

Timeframe: Screening/baseline

Each symptom will be graded by the subject based upon the subject's impression during the previous week using the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Subject Assessment of Burning/Stinging
Grade 0
27 Participants
26 Participants
Subject Assessment of Burning/Stinging
Grade 1
2 Participants
1 Participants
Subject Assessment of Burning/Stinging
Grade 2
1 Participants
3 Participants
Subject Assessment of Burning/Stinging
Grade 3
0 Participants
0 Participants
Subject Assessment of Burning/Stinging
Grade 4
0 Participants
1 Participants
Subject Assessment of Burning/Stinging
Grade 5
0 Participants
0 Participants
Subject Assessment of Burning/Stinging
Missing
0 Participants
0 Participants

SECONDARY outcome

Timeframe: Week 1

Each symptom will be graded by the subject based upon the subject's impression during the previous week using the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Subject Assessment of Burning/Stinging
Grade 0
14 Participants
15 Participants
Subject Assessment of Burning/Stinging
Grade 1
7 Participants
8 Participants
Subject Assessment of Burning/Stinging
Grade 2
3 Participants
3 Participants
Subject Assessment of Burning/Stinging
Grade 3
5 Participants
2 Participants
Subject Assessment of Burning/Stinging
Grade 4
0 Participants
0 Participants
Subject Assessment of Burning/Stinging
Grade 5
0 Participants
1 Participants
Subject Assessment of Burning/Stinging
Missing
1 Participants
2 Participants

SECONDARY outcome

Timeframe: Week 2

Each symptom will be graded by the subject based upon the subject's impression during the previous week using the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Subject Assessment of Burning/Stinging
Grade 0
22 Participants
15 Participants
Subject Assessment of Burning/Stinging
Grade 1
5 Participants
12 Participants
Subject Assessment of Burning/Stinging
Grade 2
1 Participants
2 Participants
Subject Assessment of Burning/Stinging
Grade 3
0 Participants
0 Participants
Subject Assessment of Burning/Stinging
Grade 4
0 Participants
0 Participants
Subject Assessment of Burning/Stinging
Grade 5
0 Participants
0 Participants
Subject Assessment of Burning/Stinging
Missing
2 Participants
2 Participants

SECONDARY outcome

Timeframe: Week 4

Each symptom will be graded by the subject based upon the subject's impression during the previous week using the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Subject Assessment of Burning/Stinging
Grade 0
23 Participants
14 Participants
Subject Assessment of Burning/Stinging
Grade 1
4 Participants
15 Participants
Subject Assessment of Burning/Stinging
Grade 2
0 Participants
1 Participants
Subject Assessment of Burning/Stinging
Grade 3
0 Participants
1 Participants
Subject Assessment of Burning/Stinging
Grade 4
0 Participants
0 Participants
Subject Assessment of Burning/Stinging
Grade 5
0 Participants
0 Participants
Subject Assessment of Burning/Stinging
Missing
3 Participants
0 Participants

SECONDARY outcome

Timeframe: Screening/Baseline

Each symptom will be graded by the subject based upon the subject's impression during the previous week using the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Subject Assessment of Itching
Grade 0
25 Participants
21 Participants
Subject Assessment of Itching
Grade 1
3 Participants
6 Participants
Subject Assessment of Itching
Grade 2
2 Participants
2 Participants
Subject Assessment of Itching
Grade 3
0 Participants
2 Participants
Subject Assessment of Itching
Grade 4
0 Participants
0 Participants
Subject Assessment of Itching
Grade 5
0 Participants
0 Participants
Subject Assessment of Itching
Missing
0 Participants
0 Participants

SECONDARY outcome

Timeframe: Week 1

Each symptom will be graded by the subject based upon the subject's impression during the previous week using the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Subject Assessment of Itching
Grade 0
13 Participants
14 Participants
Subject Assessment of Itching
Grade 1
6 Participants
9 Participants
Subject Assessment of Itching
Grade 2
8 Participants
6 Participants
Subject Assessment of Itching
Grade 3
2 Participants
0 Participants
Subject Assessment of Itching
Grade 4
0 Participants
0 Participants
Subject Assessment of Itching
Grade 5
0 Participants
0 Participants
Subject Assessment of Itching
Missing
1 Participants
2 Participants

SECONDARY outcome

Timeframe: Week 2

Each symptom will be graded by the subject based upon the subject's impression during the previous week using the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Subject Assessment of Itching
Grade 0
18 Participants
18 Participants
Subject Assessment of Itching
Grade 1
6 Participants
10 Participants
Subject Assessment of Itching
Grade 2
3 Participants
1 Participants
Subject Assessment of Itching
Grade 3
1 Participants
0 Participants
Subject Assessment of Itching
Grade 4
0 Participants
0 Participants
Subject Assessment of Itching
Grade 5
0 Participants
0 Participants
Subject Assessment of Itching
Missing
2 Participants
2 Participants

SECONDARY outcome

Timeframe: Week 4

Each symptom will be graded by the subject based upon the subject's impression during the previous week using the following scale: 0 - None 1. \- Trace 2. \- Mild 3. \- Moderate 4. \- Marked 5. \- Severe

Outcome measures

Outcome measures
Measure
CTGel Plus BPO Wash
n=30 Participants
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 Participants
Soap Free Cleanser in the morning and CTGel in the evening
Subject Assessment of Itching
Grade 0
18 Participants
21 Participants
Subject Assessment of Itching
Grade 1
9 Participants
8 Participants
Subject Assessment of Itching
Grade 2
0 Participants
2 Participants
Subject Assessment of Itching
Grade 3
0 Participants
0 Participants
Subject Assessment of Itching
Grade 4
0 Participants
0 Participants
Subject Assessment of Itching
Grade 5
0 Participants
0 Participants
Subject Assessment of Itching
Missing
3 Participants
0 Participants

Adverse Events

CTGel Plus BPO Wash

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

CTGel

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
CTGel Plus BPO Wash
n=30 participants at risk
BPO Wash in the morning and CTGel in the evening
CTGel
n=31 participants at risk
Soap Free Cleanser in the morning and CTGel in the evening
General disorders
Application site dryness
0.00%
0/30
9.7%
3/31
Infections and infestations
Nasopharyngitis
3.3%
1/30
6.5%
2/31

Additional Information

GSK Response Center

GlaxoSmithKline

Phone: 866-435-7343

Results disclosure agreements

  • Principal investigator is a sponsor employee GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
  • Publication restrictions are in place

Restriction type: OTHER